BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10861294)

  • 1. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis.
    Strissel PL; Strick R; Tomek RJ; Roe BA; Rowley JD; Zeleznik-Le NJ
    Hum Mol Genet; 2000 Jul; 9(11):1671-9. PubMed ID: 10861294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
    Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.
    Strout MP; Marcucci G; Bloomfield CD; Caligiuri MA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2390-5. PubMed ID: 9482895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.
    Raffini LJ; Slater DJ; Rappaport EF; Lo Nigro L; Cheung NK; Biegel JA; Nowell PC; Lange BJ; Felix CA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4568-73. PubMed ID: 11930009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
    Slany RK; Lavau C; Cleary ML
    Mol Cell Biol; 1998 Jan; 18(1):122-9. PubMed ID: 9418860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
    Mirault ME; Boucher P; Tremblay A
    Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
    Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
    Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.
    Skucha A; Ebner J; Schmöllerl J; Roth M; Eder T; César-Razquin A; Stukalov A; Vittori S; Muhar M; Lu B; Aichinger M; Jude J; Müller AC; Győrffy B; Vakoc CR; Valent P; Bennett KL; Zuber J; Superti-Furga G; Grebien F
    Nat Commun; 2018 May; 9(1):1983. PubMed ID: 29777171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9.
    Zhang LS; Kang X; Lu J; Zhang Y; Wu X; Wu G; Zheng J; Tuladhar R; Shi H; Wang Q; Morlock L; Yao H; Huang LJ; Maire P; Kim J; Williams N; Xu J; Chen C; Zhang CC; Lum L
    EBioMedicine; 2019 Jan; 39():145-158. PubMed ID: 30528456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors.
    Yang Y; Ahmad E; Premkumar V; Liu A; Ashikur Rahman SM; Nikolovska-Coleska Z
    Protein Sci; 2024 Jun; 33(6):e5019. PubMed ID: 38747396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.
    Harris WJ; Huang X; Lynch JT; Spencer GJ; Hitchin JR; Li Y; Ciceri F; Blaser JG; Greystoke BF; Jordan AM; Miller CJ; Ogilvie DJ; Somervaille TC
    Cancer Cell; 2012 Apr; 21(4):473-87. PubMed ID: 22464800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.
    Hsieh JJ; Ernst P; Erdjument-Bromage H; Tempst P; Korsmeyer SJ
    Mol Cell Biol; 2003 Jan; 23(1):186-94. PubMed ID: 12482972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
    Thys RG; Lehman CE; Pierce LC; Wang YH
    Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.
    Tariq M; Shahab S; Saeed JR; Hussain Z; Zaidi U; Farzana T; Ahmad S
    J Coll Physicians Surg Pak; 2024 Apr; 34(4):424-428. PubMed ID: 38576284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.
    Gale KB; Ford AM; Repp R; Borkhardt A; Keller C; Eden OB; Greaves MF
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13950-4. PubMed ID: 9391133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis.
    Stavast CJ; van Zuijen I; Karkoulia E; Özçelik A; van Hoven-Beijen A; Leon LG; Voerman JSA; Janssen GMC; van Veelen PA; Burocziova M; Brouwer RWW; van IJcken WFJ; Maas A; Bindels EM; van der Velden VHJ; Schliehe C; Katsikis PD; Alberich-Jorda M; Erkeland SJ
    Leukemia; 2022 Mar; 36(3):687-700. PubMed ID: 34741119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of ADAR1 on the development of MLL-AF9 induced murine AML].
    Peng L; Yang X; Zhang Y; Hu T; Wang W; Wang X; Xu J; Cheng T; Yuan W; Gao Y
    Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):383-8. PubMed ID: 26031523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional chromatin landscapes in MLLr AML.
    Sui P; Wang Z; Zhang P; Pan F
    Exp Hematol Oncol; 2024 May; 13(1):56. PubMed ID: 38778427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cohesin loss and MLL-AF9 are not synthetic lethal in murine hematopoietic stem and progenitor cells.
    Meyer A; Stelloh C; Zhu N; Rao S
    Res Sq; 2024 Jan; ():. PubMed ID: 38352423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How chromosomal translocations arise to cause cancer: Gene proximity,
    Streb P; Kowarz E; Benz T; Reis J; Marschalek R
    iScience; 2023 Jun; 26(6):106900. PubMed ID: 37378346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.